Comparative efficacy of glucocorticoid receptor agonists on Th2 cell function and attenuation by progesterone
- PDF / 1,144,657 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 82 Downloads / 200 Views
RESEARCH ARTICLE
Open Access
Comparative efficacy of glucocorticoid receptor agonists on Th2 cell function and attenuation by progesterone Alexander Luchak1, Lauren A. Solomon1, Tharsan Kanagalingam1, Meerah Vijeyakumaran1, Brian H. Rowe2 and Lisa Cameron1*
Abstract Background: Corticosteroids (CS)s suppress cytokine production and induce apoptosis of inflammatory cells. Prednisone and dexamethasone are oral CSs prescribed for treating asthma exacerbations. While prednisone is more commonly prescribed, dexamethasone is long acting and a more potent glucocorticoid receptor (GR) agonist. It can be administered as a one or two dose regime, unlike the five to seven days required for prednisone, a feature that increases compliance. We compared the relative ability of these two oral CSs to suppress type 2 inflammation. Since progesterone has affinity for the GR and women are more likely to relapse following an asthma exacerbation, we assessed its influence on CS action. Results: Dexamethasone suppressed the level of IL-5 and IL-13 mRNA within Th2 cells with ~ 10-fold higher potency than prednisolone (the active form of prednisone). Dexamethasone induced a higher proportion of apoptotic and dying cells than prednisolone, at all concentrations examined. Addition of progesterone reduced the capacity of both CS to drive cell death, though dexamethasone maintained significantly more killing activity. Progesterone blunted dexamethasone-induction of FKBP5 mRNA, indicating that the mechanism of action was by interference of the CS:GR complex. Conclusions: Dexamethasone is both more potent and effective than prednisolone in suppressing type 2 cytokine levels and mediating apoptosis. Progesterone attenuated these anti-inflammatory effects, indicating its potential influence on CS responses in vivo. Collectively, our data suggest that when oral CS is required, dexamethasone may be better able to control type 2 inflammation, eliminate Th2 cells and ultimately lead to improved long-term outcomes. Further research in asthmatics is needed. Keywords: Asthma, Th2 cells, Type 2 cytokine, IL-13, Apoptosis, Corticosteroid, Sex hormone, Progesterone
* Correspondence: [email protected] 1 Department of Pathology and Laboratory Medicine, Western University, 1151 Richmond Street, Dental Science Building Rm. 4037, London, Ontario N6A 5C1, Canada Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence an
Data Loading...
